{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:25:15Z","timestamp":1789629915554,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00281-015-0512-6","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T03:30:40Z","timestamp":1438140640000},"page":"501-509","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Gene expression profiling offers insights into the role of innate immune signaling in SSc"],"prefix":"10.1007","volume":"37","author":[{"given":"Michael E.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Pioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Whitfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"key":"512_CR1","doi-asserted-by":"crossref","first-page":"e2696","DOI":"10.1371\/journal.pone.0002696","volume":"3","author":"A Milano","year":"2008","unstructured":"Milano A et al (2008) Molecular subsets in the gene expression signatures of scleroderma skin. PLoS One 3:e2696","journal-title":"PLoS One"},{"key":"512_CR2","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/jid.2011.472","volume":"132","author":"SA Pendergrass","year":"2012","unstructured":"Pendergrass SA, Lemaire R, Francis IP, Mahoney JM, Lafyatis R, Whitfield ML (2012) Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies. J Invest Dermatol 132:1363\u20131373","journal-title":"J Invest Dermatol"},{"key":"512_CR3","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/jid.2013.130","volume":"133","author":"M Hinchcliff","year":"2013","unstructured":"Hinchcliff M et al (2013) Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis. J Invest Dermatol 133:1979\u20131989","journal-title":"J Invest Dermatol"},{"key":"512_CR4","doi-asserted-by":"crossref","first-page":"e1004005","DOI":"10.1371\/journal.pcbi.1004005","volume":"11","author":"JM Mahoney","year":"2015","unstructured":"Mahoney JM et al (2015) Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms. PLoS Comput Biol 11:e1004005","journal-title":"PLoS Comput Biol"},{"key":"512_CR5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/art.30159","volume":"63","author":"E Hsu","year":"2011","unstructured":"Hsu E, Shi H, Jordan RM, Lyons-Weiler J, Pilewski JM, Feghali-Bostwick CA (2011) Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension. Arthritis Rheum 63:783\u2013794","journal-title":"Arthritis Rheum"},{"key":"512_CR6","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/art.38288","volume":"66","author":"RB Christmann","year":"2014","unstructured":"Christmann RB et al (2014) Association of interferon- and transforming growth factor beta-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis. Arthritis Rheumatol 66:714\u2013725","journal-title":"Arthritis Rheumatol"},{"key":"512_CR7","doi-asserted-by":"crossref","first-page":"12319","DOI":"10.1073\/pnas.1635114100","volume":"100","author":"ML Whitfield","year":"2003","unstructured":"Whitfield ML et al (2003) Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc Natl Acad Sci U S A 100:12319\u201312324","journal-title":"Proc Natl Acad Sci U S A"},{"key":"512_CR8","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.21894","volume":"54","author":"H Gardner","year":"2006","unstructured":"Gardner H et al (2006) Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts. Arthritis Rheum 54:1961\u20131973","journal-title":"Arthritis Rheum"},{"key":"512_CR9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM et al (2000) Molecular portraits of human breast tumours. Nature 406:747\u2013752","journal-title":"Nature"},{"key":"512_CR10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503\u2013511","journal-title":"Nature"},{"key":"512_CR11","doi-asserted-by":"crossref","first-page":"13784","DOI":"10.1073\/pnas.241500798","volume":"98","author":"ME Garber","year":"2001","unstructured":"Garber ME et al (2001) Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A 98:13784\u201313789","journal-title":"Proc Natl Acad Sci U S A"},{"key":"512_CR12","doi-asserted-by":"crossref","first-page":"13790","DOI":"10.1073\/pnas.191502998","volume":"98","author":"A Bhattacharjee","year":"2001","unstructured":"Bhattacharjee A et al (2001) Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 98:13790\u201313795","journal-title":"Proc Natl Acad Sci U S A"},{"key":"512_CR13","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","volume":"100","author":"T Sorlie","year":"2003","unstructured":"Sorlie T et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100:8418\u20138423","journal-title":"Proc Natl Acad Sci U S A"},{"key":"512_CR14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/art.24249","volume":"60","author":"R Lafyatis","year":"2009","unstructured":"Lafyatis R et al (2009) B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum 60:578\u2013583","journal-title":"Arthritis Rheum"},{"key":"512_CR15","doi-asserted-by":"crossref","unstructured":"Chakravarty EF et al (2015). A pilot randomized placebo-controlled study of abatacept for the treatment of diffuse cutaneous systemic sclerosis. Arthritis Res Ther. In press.","DOI":"10.1186\/s13075-015-0669-3"},{"key":"512_CR16","doi-asserted-by":"crossref","unstructured":"Gordon JK et al (2015). Nilotinib in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial. Arthritis Res Ther. Submitted.","DOI":"10.1186\/s13075-015-0721-3"},{"key":"512_CR17","doi-asserted-by":"crossref","unstructured":"Assassi S et al (2015). Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis. Arthritis Rheum. In Press.","DOI":"10.1002\/art.39289"},{"key":"512_CR18","doi-asserted-by":"crossref","first-page":"W484","DOI":"10.1093\/nar\/gks458","volume":"40","author":"AK Wong","year":"2012","unstructured":"Wong AK, Park CY, Greene CS, Bongo LA, Guan Y, Troyanskaya OG (2012) IMP: a multi-species functional genomics portal for integration, visualization and prediction of protein functions and networks. Nucleic Acids Res 40:W484\u2013W490","journal-title":"Nucleic Acids Res"},{"key":"512_CR19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1741-7015-11-9","volume":"11","author":"S Assassi","year":"2013","unstructured":"Assassi S, Radstake TR, Mayes MD, Martin J (2013) Genetics of scleroderma: implications for personalized medicine? BMC Med 11:9","journal-title":"BMC Med"},{"key":"512_CR20","unstructured":"Taroni J et al (2015). Genome-wide gene expression analysis of systemic sclerosis esophageal biopsies identifies disease-specific molecular subsets. Arthritis Res Ther. In press."},{"key":"512_CR21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/art.24221","volume":"60","author":"L Chung","year":"2009","unstructured":"Chung L et al (2009) Molecular framework for response to imatinib mesylate in systemic sclerosis. Arthritis Rheum 60:584\u2013591","journal-title":"Arthritis Rheum"},{"key":"512_CR22","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/jid.2009.318","volume":"130","author":"JL Sargent","year":"2009","unstructured":"Sargent JL et al (2009) A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity. J Invest Dermatol 130:694\u2013705","journal-title":"J Invest Dermatol"},{"key":"512_CR23","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ajpath.2011.11.024","volume":"180","author":"MB Greenblatt","year":"2012","unstructured":"Greenblatt MB et al (2012) Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets. Am J Pathol 180:1080\u20131094","journal-title":"Am J Pathol"},{"key":"512_CR24","doi-asserted-by":"crossref","first-page":"e0114017","DOI":"10.1371\/journal.pone.0114017","volume":"10","author":"ME Johnson","year":"2015","unstructured":"Johnson ME et al (2015) Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts. PLoS One 10:e0114017","journal-title":"PLoS One"},{"key":"512_CR25","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1186\/1755-1536-5-S1-S18","volume":"5","author":"S Bhattacharyya","year":"2012","unstructured":"Bhattacharyya S, Wei J, Tourtellotte WG, Hinchcliff M, Gottardi CG, Varga J (2012) Fibrosis in systemic sclerosis: common and unique pathobiology. Fibrogenesis Tissue Repair 5:S18","journal-title":"Fibrogenesis Tissue Repair"},{"key":"512_CR26","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/jid.2013.423","volume":"134","author":"A Farina","year":"2014","unstructured":"Farina A et al (2014) Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in scleroderma. J Invest Dermatol 134:954\u2013964","journal-title":"J Invest Dermatol"},{"key":"512_CR27","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1136\/ard.2009.128207","volume":"69","author":"L Bon van","year":"2010","unstructured":"van Bon L et al (2010) Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 69:1539\u20131547","journal-title":"Ann Rheum Dis"},{"key":"512_CR28","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1002\/art.30568","volume":"63","author":"CM Artlett","year":"2011","unstructured":"Artlett CM, Sassi-Gaha S, Rieger JL, Boesteanu AC, Feghali-Bostwick CA, Katsikis PD (2011) The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis. Arthritis Rheum 63:3563\u20133574","journal-title":"Arthritis Rheum"},{"key":"512_CR29","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1038\/jid.2014.127","volume":"134","author":"ST Arron","year":"2014","unstructured":"Arron ST et al (2014) High Rhodotorula sequences in skin transcriptome of patients with diffuse systemic sclerosis. J Invest Dermatol 134:2138\u20132145","journal-title":"J Invest Dermatol"},{"key":"512_CR30","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/art.30318","volume":"63","author":"RB Christmann","year":"2011","unstructured":"Christmann RB et al (2011) Interferon and alternative activation of monocyte\/macrophages in systemic sclerosis-associated pulmonary arterial hypertension. Arthritis Rheum 63:1718\u20131728","journal-title":"Arthritis Rheum"},{"key":"512_CR31","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1136\/annrheumdis-2012-202814","volume":"73","author":"AL Mathes","year":"2014","unstructured":"Mathes AL et al (2014) Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin. Ann Rheum Dis 73:1864\u20131872","journal-title":"Ann Rheum Dis"},{"key":"512_CR32","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958\u2013969","journal-title":"Nat Rev Immunol"},{"key":"512_CR33","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/ar3066","volume":"12","author":"N Higashi-Kuwata","year":"2010","unstructured":"Higashi-Kuwata N et al (2010) Characterization of monocyte\/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis. Arthritis Res Ther 12:R128","journal-title":"Arthritis Res Ther"},{"key":"512_CR34","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1359-6101(03)00060-1","volume":"14","author":"SP Atamas","year":"2003","unstructured":"Atamas SP, White B (2003) Cytokine regulation of pulmonary fibrosis in scleroderma. Cytokine Growth Factor Rev 14:537\u2013550","journal-title":"Cytokine Growth Factor Rev"},{"key":"512_CR35","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0190-9622(84)70191-5","volume":"11","author":"ZY Chen","year":"1984","unstructured":"Chen ZY et al (1984) Immune complexes and antinuclear, antinucleolar, and anticentromere antibodies in scleroderma. J Am Acad Dermatol 11:461\u2013467","journal-title":"J Am Acad Dermatol"},{"key":"512_CR36","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/art.1780251004","volume":"25","author":"JR Seibold","year":"1982","unstructured":"Seibold JR, Medsger TA Jr, Winkelstein A, Kelly RH, Rodnan GP (1982) Immune complexes in progressive systemic sclerosis (scleroderma). Arthritis Rheum 25:1167\u20131173","journal-title":"Arthritis Rheum"},{"key":"512_CR37","first-page":"328","volume":"24","author":"M Hasegawa","year":"1997","unstructured":"Hasegawa M, Fujimoto M, Kikuchi K, Takehara K (1997) Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol 24:328\u2013332","journal-title":"J Rheumatol"},{"key":"512_CR38","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","volume":"18","author":"A Leask","year":"2004","unstructured":"Leask A, Abraham DJ (2004) TGF-beta signaling and the fibrotic response. Faseb J 18:816\u2013827","journal-title":"Faseb J"},{"key":"512_CR39","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nrrheum.2009.26","volume":"5","author":"J Varga","year":"2009","unstructured":"Varga J, Pasche B (2009) Transforming growth factor beta as a therapeutic target in systemic sclerosis. Nat Rev Rheumatol 5:200\u2013206","journal-title":"Nat Rev Rheumatol"},{"key":"512_CR40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","volume":"3","author":"S Gordon","year":"2003","unstructured":"Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23\u201335","journal-title":"Nat Rev Immunol"},{"key":"512_CR41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.immuni.2006.07.011","volume":"25","author":"MO Li","year":"2006","unstructured":"Li MO, Sanjabi S, Flavell RA (2006) Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25:455\u2013471","journal-title":"Immunity"},{"key":"512_CR42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-immunol-031210-101345","volume":"29","author":"B Reizis","year":"2011","unstructured":"Reizis B, Bunin A, Ghosh HS, Lewis KL, Sisirak V (2011) Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol 29:163\u2013183","journal-title":"Annu Rev Immunol"},{"key":"512_CR43","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/art.27224","volume":"62","author":"S Assassi","year":"2010","unstructured":"Assassi S et al (2010) Systemic sclerosis and lupus: points in an interferon-mediated continuum. Arthritis Rheum 62:589\u2013598","journal-title":"Arthritis Rheum"},{"key":"512_CR44","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/ard.2009.121400","volume":"69","author":"ML Eloranta","year":"2010","unstructured":"Eloranta ML et al (2010) Type I interferon system activation and association with disease manifestations in systemic sclerosis. Ann Rheum Dis 69:1396\u20131402","journal-title":"Ann Rheum Dis"},{"key":"512_CR45","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/art.23486","volume":"58","author":"D Kim","year":"2008","unstructured":"Kim D et al (2008) Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis. Arthritis Rheum 58:2163\u20132173","journal-title":"Arthritis Rheum"},{"key":"512_CR46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","volume":"370","author":"L Bon van","year":"2014","unstructured":"van Bon L et al (2014) Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. NEJM 370:433\u2013443","journal-title":"NEJM"},{"key":"512_CR47","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1165\/ajrcmb.26.5.4683","volume":"26","author":"IG Luzina","year":"2002","unstructured":"Luzina IG, Atamas SP, Wise R, Wigley FM, Xiao HQ, White B (2002) Gene expression in bronchoalveolar lavage cells from scleroderma patients. Am J Respir Cell Mol Biol 26:549\u2013557","journal-title":"Am J Respir Cell Mol Biol"},{"key":"512_CR48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0923-1811(92)90026-8","volume":"3","author":"V Falanga","year":"1992","unstructured":"Falanga V, Gerhardt CO, Dasch JR, Takehara K, Ksander GA (1992) Skin distribution and differential expression of transforming growth factor \u03b21 and \u03b22. J Dermatol Sci 3:131\u2013136","journal-title":"J Dermatol Sci"},{"key":"512_CR49","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/clin.1993.1170","volume":"69","author":"PP Sfikakis","year":"1993","unstructured":"Sfikakis PP, McCune BK, Tsokos M, Aroni K, Vayiopoulos G, Tsokos GC (1993) Immunohistological demonstration of transforming growth factor-\u03b2 isoforms in the skin of patients with systemic sclerosis. Clin Immunol Immunopathol 69:199\u2013204","journal-title":"Clin Immunol Immunopathol"},{"key":"512_CR50","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1600-0625.2008.00828.x","volume":"18","author":"N Higashi-Kuwata","year":"2009","unstructured":"Higashi-Kuwata N, Makino T, Inoue Y, Takeya M, Ihn H (2009) Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma. Exp Dermatol 18:727\u2013729","journal-title":"Exp Dermatol"},{"key":"512_CR51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2010.06.017","volume":"137","author":"DV Pechkovsky","year":"2010","unstructured":"Pechkovsky DV et al (2010) Alternatively activated alveolar macrophages in pulmonary fibrosis\u2014mediator production and intracellular signal transduction. Clin Immunol 137:89\u2013101","journal-title":"Clin Immunol"},{"key":"512_CR52","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar3486","volume":"13","author":"M-E Truchetet","year":"2011","unstructured":"Truchetet M-E, Brembilla NC, Montanari E, Allanore Y, Chizzolini C (2011) Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arth Res Ther 13:R166","journal-title":"Arth Res Ther"},{"key":"512_CR53","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1023\/B:JOCI.0000018060.36183.bb","volume":"24","author":"A Kessel","year":"2004","unstructured":"Kessel A et al (2004) Increased CD8+ T cell apoptosis in scleroderma is associated with low levels of NF-kappa B. J Clin Immunol 24:30\u201336","journal-title":"J Clin Immunol"},{"key":"512_CR54","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/annrheumdis-2011-200709","volume":"71","author":"A Mathian","year":"2012","unstructured":"Mathian A et al (2012) Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions. Ann Rheum Dis 71:1227\u20131234","journal-title":"Ann Rheum Dis"},{"key":"512_CR55","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jdermsci.2008.01.001","volume":"50","author":"M Murata","year":"2008","unstructured":"Murata M et al (2008) Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease? J Dermatol Sci 50:240\u2013242","journal-title":"J Dermatol Sci"},{"key":"512_CR56","doi-asserted-by":"crossref","first-page":"e5903","DOI":"10.1371\/journal.pone.0005903","volume":"4","author":"TR Radstake","year":"2009","unstructured":"Radstake TR et al (2009) The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGF\u03b2 and IFN\u03b3 distinguishes SSc phenotypes. PLoS One 4:e5903","journal-title":"PLoS One"},{"key":"512_CR57","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s00296-011-2056-y","volume":"32","author":"TS Rodr\u00edguez-Reyna","year":"2012","unstructured":"Rodr\u00edguez-Reyna TS et al (2012) Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study. Rheumatol Int 32:2653\u20132660","journal-title":"Rheumatol Int"},{"key":"512_CR58","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ncprheum0618","volume":"3","author":"B Deleuran","year":"2007","unstructured":"Deleuran B, Abraham DJ (2007) Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma. Nat Clin Pract Rheum 3:682\u2013683","journal-title":"Nat Clin Pract Rheum"},{"key":"512_CR59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-065X.2012.01131.x","volume":"248","author":"RC Axtell","year":"2012","unstructured":"Axtell RC, Raman C (2012) Janus-like effects of type I interferon in autoimmune diseases. Immunol Rev 248:23\u201335","journal-title":"Immunol Rev"},{"key":"512_CR60","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1136\/gut.2008.163667","volume":"58","author":"S Brand","year":"2009","unstructured":"Brand S (2009) Crohn\u2019s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn\u2019s disease. Gut 58:1152\u20131167","journal-title":"Gut"},{"key":"512_CR61","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.2741\/4054","volume":"17","author":"A Camporeale","year":"2012","unstructured":"Camporeale A (2012) IL-6, IL-17, and STAT3: a holy trinity in auto-immunity? Front Biosci 17:2306\u20132326","journal-title":"Front Biosci"},{"key":"512_CR62","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.intimp.2010.10.004","volume":"11","author":"A Kimura","year":"2011","unstructured":"Kimura A, Kishimoto T (2011) Th17 cells in inflammation. Int Immunopharmacol 11:319\u2013322","journal-title":"Int Immunopharmacol"},{"key":"512_CR63","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-0348-0522-3_6","volume-title":"IL-17, IL-22 and their producing cells: role in inflammation and autoimmunity: springer","author":"SG Zheng","year":"2013","unstructured":"Zheng SG (2013) Regulatory T cells versus Th17: differentiation of Th17 versus Treg, are they mutually exclusive? In: IL-17, IL-22 and their producing cells: role in inflammation and autoimmunity: springer., pp 91\u2013107"},{"key":"512_CR64","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nm1551","volume":"13","author":"L Steinman","year":"2007","unstructured":"Steinman L (2007) A brief history of TH17, the first major revision in the TH1\/TH2 hypothesis of T cell-mediated tissue damage. Nat Med 13:139\u2013145","journal-title":"Nat Med"},{"key":"512_CR65","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/art.38990","volume":"67","author":"RG Marangoni","year":"2015","unstructured":"Marangoni RG et al (2015) Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors. Arthritis Rheumatol 67:1062\u20131073","journal-title":"Arthritis Rheumatol"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-015-0512-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00281-015-0512-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-015-0512-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T06:12:15Z","timestamp":1559023935000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-015-0512-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["512"],"URL":"https:\/\/doi.org\/10.1007\/s00281-015-0512-6","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]}}}